These results indicated that FOXM1 is upregulated in resistant cancer cells and that reduced expression of FOXM1 enhances their sensitivity to radiation, which may provide a new approach to elevating the sensitivity to treatment in patients with lung cancer. This evidence concerns the gene FOXM1 and cancer.